Published online February 2, 2007
Diabetes Care
30:980-986,
2007
DOI: 10.2337/dc06-1994
© 2007 by the American Diabetes Association
Cardiovascular and Metabolic Risk Original Article |
The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults
Anastassios G. Pittas, MD, MSC1,
Susan S. Harris, DSC2,
Paul C. Stark, SCD3 and
Bess Dawson-Hughes, MD1,2
1 Department of Endocrinology, Diabetes, and Metabolism, TuftsNew England Medical Center, Boston, Massachusetts
2 Bone Metabolism Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts
3 Institute for Clinical Research and Health Policy Studies, TuftsNew England Medical Center, Boston, Massachusetts
Address correspondence and reprint requests to Anastassios G. Pittas, MD, M.Sc., Department of Endocrinology, Diabetes, and Metabolism, TuftsNew England Medical Center, 750 Washington St., 268, Boston, MA 02111. E-mail: apittas{at}tufts-nemc.org
OBJECTIVEWe sought to compare the effects of combined calcium and vitamin D supplementation versus placebo on blood glucose and markers of inflammation in nondiabetic adults aged 65 years.
RESEARCH DESIGN AND METHODSA total of 314 Caucasian adults without diabetes received either 500 mg calcium citrate and 700 IU vitamin D3 or placebos daily for 3 years in a double-blind, randomized, controlled trial designed for bone-related outcomes. In a post hoc analysis, fasting plasma glucose (FPG), insulin sensitivity (estimated by homeostasis model assessment of insulin resistance [HOMA-IR]), plasma C-reactive protein, and interleukin-6, were measured at baseline and 3 years.
RESULTSThe effects of combined calciumvitamin D supplementation on 3-year change in FPG depended on baseline FPG (P = 0.02 for interaction). Therefore, we conducted analyses separately in participants with normal fasting glucose (NFG) (FPG <5.6 mmol/l, n = 222) and impaired fasting glucose (IFG) (FPG 5.66.9 mmol/l, n = 92) at baseline. Among participants with IFG at baseline, those who took combined calciumvitamin D supplements had a lower rise in FPG at 3 years compared with those on placebo (0.02 mmol/l [0.4 mg/dl] vs. 0.34 mmol/l [6.1 mg/dl], respectively, P = 0.042) and a lower increase in HOMA-IR (0.05 vs. 0.91, P = 0.031). In the NFG subgroup, there was no difference in the change in FPG or HOMA-IR between the two treatment arms. There were no differences in C-reactive protein or interleukin-6 between the two treatment arms in either subgroup.
CONCLUSIONSIn healthy, older adults with IFG, supplementation with calcium and vitamin D may attenuate increases in glycemia and insulin resistance that occur over time. However, our findings should be considered hypothesis generating and need to be confirmed in randomized trials specifically designed for the outcomes of interest.
Abbreviations: FPG, fasting plasma glucose HOMA-IR, homeostasis model assessment of insulin resistance IFG, impaired fasting glucose NFG, normal fasting glucose PTH, parathyroid hormone

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Endocr. Rev.,
October 1, 2008;
29(6):
726 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Scragg
Vitamin D and Type 2 Diabetes: Are We Ready for a Prevention Trial?
Diabetes,
October 1, 2008;
57(10):
2565 - 2566.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Forouhi, J. Luan, A. Cooper, B. J. Boucher, and N. J. Wareham
Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance: The Medical Research Council Ely Prospective Study 1990-2000
Diabetes,
October 1, 2008;
57(10):
2619 - 2625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Giovannucci, Y. Liu, B. W. Hollis, and E. B. Rimm
25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men: A Prospective Study
Arch Intern Med,
June 9, 2008;
168(11):
1174 - 1180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Schwalfenberg
Vitamin D and diabetes: Improvement of glycemic control with vitamin D3 repletion
Can Fam Physician,
June 1, 2008;
54(6):
864 - 866.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Melamed, P. Muntner, E. D. Michos, J. Uribarri, C. Weber, J. Sharma, and P. Raggi
Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2008;
28(6):
1179 - 1185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. H. de Boer, L. F. Tinker, S. Connelly, J. D. Curb, B. V. Howard, B. Kestenbaum, J. C. Larson, J. E. Manson, K. L. Margolis, D. S. Siscovick, et al.
Calcium Plus Vitamin D Supplementation and the Risk of Incident Diabetes in the Women's Health Initiative
Diabetes Care,
April 1, 2008;
31(4):
701 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Honeyman, S. Elkassaby, and L. C. Harrison
Seasonal Changes in Preprandial Glucose, A1C, and Blood Pressure in Diabetic Patients: Response to Liang
Diabetes Care,
November 1, 2007;
30(11):
e118 - e118.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tournis and A. Mitrakou
The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults: Response to Pittas et al.
Diabetes Care,
July 1, 2007;
30(7):
e81 - e81.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Pittas and B. Dawson-Hughes
The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults: Response to Tournis and Mitrakou
Diabetes Care,
July 1, 2007;
30(7):
e82 - e82.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2017 - 2029.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Diabetes Association.
|
|
| |
|